RESULTS OF ASTRAL-1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF...

HemaSphere 2019 / 06 Vol. 3

RESULTS OF ASTRAL-1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN-AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)

Fenaux, P., Gobbi, M., Kropf, P. L., Mayer, J., Roboz, G. J., Döhner, H., Krauter, J., Döhner, K., Robak, T., Kantarjian, H., Novak, J., Jedrzejczak, W., Thomas, X., Ojeda-Uribe, M., Miyazaki, Y., M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000561796.30124.a4
Date:
June, 2019
File:
PDF, 478 KB
2019
Conversion to is in progress
Conversion to is failed